Compare Align Technology, Inc. (ALGN) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Align Technology, Inc. vs PepsiCo, Inc. — how do they compare? Align Technology, Inc. trades at $179.9 (market cap $12.86B), while PepsiCo, Inc. trades at $138.03 (market cap $187.51B). The key difference: PepsiCo, Inc. is far larger — about 14.6× Align Technology, Inc.'s market cap, and PepsiCo, Inc. pays a 4.31% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | PEP | |
|---|---|---|
Market Cap | $12.86B | $187.51B |
Sector | Health | Consumer Staples |
52-Week High | $207.19 | $170.44 |
52-Week Low | $124.88 | $133.81 |
Enterprise Value | $11.92B | $230.01B |
Dividend Yield | — | 4.31% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
PepsiCo (PEP) trades at $137.38, down 0.35% on the day, with a bearish technical signal from moving averages but neutral oscillators. The stock shows strong profitability with a 10.78% net income margin and 51.59% ROE, though revenue growth is modest. Recent news highlights price cuts on snacks like Doritos to address consumer pushback, while the company continues to beat earnings estimates, with Q3 2026 results pending.
The outlook is mixed: analyst consensus is a 'Hold' with a $159.27 price target, implying upside, but technical weakness and competitive pressures pose risks. Investment appeal lies in steady dividends and earnings beats, but margin pressures from pricing strategies and high debt levels require monitoring for sustained shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
